Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood

Acta Biomaterialia

Volumn 9, Issue 7, 2013, Pages 7460-7468

  Krajewski, Stefanie ^a   Prucek, Robert ^b   Panacek, Ales ^b   Avci Adali, Meltem ^a   Nolte, Andrea ^a   Straub, Andreas ^a   Zboril, Radek ^b   Wendel, Hans P ^a   Kvitek, Libor ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Coagulation; Hemocompatibility; Inflammation; Silver nanoparticles

Indexed keywords

BIOMEDICAL EQUIPMENT; MEDICAL APPLICATIONS; METAL NANOPARTICLES; PLATELETS; SILVER NANOPARTICLES; TESTING;

ADVERSE EFFECT; ANTIBACTERIAL EFFECTS; CHANDLER-LOOP MODEL; HAEMOCOMPATIBILITY; HUMAN BLOODS; IN-VITRO; IN-VITRO ASSAYS; MEDICAL DEVICES; NANOPARTICLE CONCENTRATIONS; WHOLE BLOOD;

COAGULATION;

SILVER NANOPARTICLE;

ARTICLE; BLOOD COMPATIBILITY; BLOOD SAMPLING; ERYTHROCYTE; EVALUATION; FLOW CYTOMETRY; GRANULOCYTE; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HUMAN; IN VITRO STUDY; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; SYNTHESIS; THROMBOCYTE ACTIVATION;

EID: 84878287428     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.03.016     Document Type: Article

References (44)

1. K. Chaloupka, Y. Malam, and A.M. Seifalian Nanosilver as a new generation of nanoproduct in biomedical applications Trends Biotechnol 28 2010 580 588
2. J. Jain, S. Arora, J.M. Rajwade, P. Omray, S. Khandelwal, and K.M. Paknikar Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use Mol Pharm 6 2009 1388 1401
3. A. Panacek, M. Kolar, R. Vecerova, R. Prucek, J. Soukupova, and V. Krystof Antifungal activity of silver nanoparticles against Candida spp Biomaterials 30 2009 6333 6340
4. A. Panacek, L. Kvitek, R. Prucek, M. Kolar, R. Vecerova, and N. Pizurova Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity J Phys Chem B 110 2006 16248 16253
5. Z. Huang, X. Jiang, D. Guo, and N. Gu Controllable synthesis and biomedical applications of silver nanomaterials J Nanosci Nanotechnol 11 2011 9395 9408
6. O. Salata Applications of nanoparticles in biology and medicine J Nanobiotechnol 2 2004 3
7. J.S. Kim, E. Kuk, K.N. Yu, J.H. Kim, S.J. Park, and H.J. Lee Antimicrobial effects of silver nanoparticles Nanomedicine 3 2007 95 101
8. F. Furno, K.S. Morley, B. Wong, B.L. Sharp, P.L. Arnold, and S.M. Howdle Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 54 2004 1019 1024
9. G. Gosheger, J. Hardes, H. Ahrens, A. Streitburger, H. Buerger, and M. Erren Silver-coated megaendoprostheses in a rabbit model - an analysis of the infection rate and toxicological side effects Biomaterials 25 2004 5547 5556
10. H.H. Lara, E.N. Garza-Trevino, L. Ixtepan-Turrent, and D.K. Singh Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds J Nanobiotechnol 9 2011 30
11. P.V. AshaRani, G. Low Kah Mun, M.P. Hande, and S. Valiyaveettil Cytotoxicity and genotoxicity of silver nanoparticles in human cells ACS Nano 3 2009 279 290
12. S. Arora, J. Jain, J.M. Rajwade, and K.M. Paknikar Cellular responses induced by silver nanoparticles: in vitro studies Toxicol Lett 179 2008 93 100
13. L. Braydich-Stolle, S. Hussain, J.J. Schlager, and M.C. Hofmann In vitro cytotoxicity of nanoparticles in mammalian germline stem cells Toxicol Sci 88 2005 412 419
14. Y.S. Kim, J.S. Kim, H.S. Cho, D.S. Rha, J.M. Kim, and J.D. Park Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats Inhal Toxicol 20 2008 575 583
15. Y.S. Kim, M.Y. Song, J.D. Park, K.S. Song, H.R. Ryu, and Y.H. Chung Subchronic oral toxicity of silver nanoparticles Part Fibre Toxicol 7 2010 20
16. J.H. Ji, J.H. Jung, S.S. Kim, J.U. Yoon, J.D. Park, and B.S. Choi Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats Inhal Toxicol 19 2007 857 871
17. E.A. Jun, K.M. Lim, K. Kim, O.N. Bae, J.Y. Noh, and K.H. Chung Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity Nanotoxicology 5 2011 157 167
18. J. Choi, V. Reipa, V.M. Hitchins, P.L. Goering, and R.A. Malinauskas Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles Toxicol Sci 123 2011 133 143
19. S.W.P. Wijnhoven, W.J.G.M. Peijnenburg, C.A. Herberts, W.I. Hagens, A.G. Oomen, and E.H.W. Heugens Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment Nanotoxicology 3 2009 U78 U109
20. F. Martinez-Gutierrez, E.P. Thi, J.M. Silverman, C.C. de Oliveira, S.L. Svensson, and A. Vanden Hoek Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles Nanomedicine 8 2012 328 336
21. L. Kvitek, M. Vanickova, A. Panacek, J. Soukupova, M. Dittrich, and E. Valentova Initial study on the toxicity of silver nanoparticles (NPs) against Paramecium caudatum J Phys Chem C 113 2009 4296 4300
22. S. Sinn, T. Scheuermann, S. Deichelbohrer, G. Ziemer, and H.P. Wendel A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4 J Mater Sci Mater Med 22 2011 1521 1528
23. A. Paul, M. Avci-Adali, B. Neumann, K. Guo, A. Straub, and K. Dietz Aptamers influence the hemostatic system by activating the intrinsic coagulation pathway in an in vitro Chandler-loop model Clin Appl Thromb Hemost 16 2010 161 169
24. A. Straub, M. Breuer, H.P. Wendel, K. Peter, K. Dietz, and G. Ziemer Critical temperature ranges of hypothermia-induced platelet activation: possible implications for cooling patients in cardiac surgery Thromb Haemost 97 2007 608 616
25. A. Straub, S. Krajewski, J.D. Hohmann, E. Westein, F. Jia, and N. Bassler Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target Arterioscler Thromb Vasc Biol 31 2011 1607 1616
26. E.J. Park, J. Yi, Y. Kim, K. Choi, and K. Park Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism Toxicol In Vitro 24 2010 872 878
27. J. Fu, J. Ji, D. Fan, and J. Shen Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex J Biomed Mater Res A 79 2006 665 674
28. M.J. Piao, K.A. Kang, I.K. Lee, H.S. Kim, S. Kim, and J.Y. Choi Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis Toxicol Lett 201 2011 92 100
29. R.P. Nishanth, R.G. Jyotsna, J.J. Schlager, S.M. Hussain, and P. Reddanna Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: role of ROS-NFkappaB signaling pathway Nanotoxicology 5 2011 502 516
30. R. Foldbjerg, P. Olesen, M. Hougaard, D.A. Dang, H.J. Hoffmann, and H. Autrup PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes Toxicol Lett 190 2009 156 162
31. Y.H. Hsin, C.F. Chen, S. Huang, T.S. Shih, P.S. Lai, and P.J. Chueh The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells Toxicol Lett 179 2008 130 139
32. C. Carlson, S.M. Hussain, A.M. Schrand, L.K. Braydich-Stolle, K.L. Hess, and R.L. Jones Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species J Phys Chem B 112 2008 13608 13619
33. J.H. Sung, J.H. Ji, J.D. Park, J.U. Yoon, D.S. Kim, and K.S. Jeon Subchronic inhalation toxicity of silver nanoparticles Toxicol Sci 108 2009 452 461
34. J. Tang, L. Xiong, S. Wang, J. Wang, L. Liu, and J. Li Distribution, translocation and accumulation of silver nanoparticles in rats J Nanosci Nanotechnol 9 2009 4924 4932
35. D.P. Lankveld, A.G. Oomen, P. Krystek, A. Neigh, A. Troost-de Jong, and C.W. Noorlander The kinetics of the tissue distribution of silver nanoparticles of different sizes Biomaterials 31 2010 8350 8361
36. A. Ravindran, A. Singh, A.M. Raichur, N. Chandrasekaran, and A. Mukherjee Studies on interaction of colloidal Ag nanoparticles with bovine serum albumin (BSA) Colloid Surf B 76 2010 32 37
37. S. Grade, J. Eberhard, P. Wagener, A. Winkel, C.L. Sajti, and S. Barcikowski Therapeutic window of ligand-free silver nanoparticles in agar-embedded and colloidal state: in vitro bactericidal effects and cytotoxicity Adv Eng Mater 14 2012 B231 B239
38. M. Raffi, F. Hussain, T.M. Bhatti, J.I. Akhter, A. Hameed, and M.M. Hasan Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224 J Mater Sci Technol 24 2008 192 196
39. S. Shrivastava, T. Bera, S.K. Singh, G. Singh, P. Ramachandrarao, and D. Dash Characterization of antiplatelet properties of silver nanoparticles ACS Nano 3 2009 1357 1364
40. S.H. Shin, M.K. Ye, H.S. Kim, and H.S. Kang The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells Int Immunopharmacol 7 2007 1813 1818
41. M.V. Park, A.M. Neigh, J.P. Vermeulen, L.J. de la Fonteyne, H.W. Verharen, and J.J. Briede The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles Biomaterials 32 2011 9810 9817
42. C. Greulich, J. Diendorf, J. Gessmann, T. Simon, T. Habijan, and G. Eggeler Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles Acta Biomater 7 2011 3505 3514
43. H.J. Yen, S.H. Hsu, and C.L. Tsai Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes Small 5 2009 1553 1561
44. M.C. Stensberg, Q. Wei, E.S. McLamore, D.M. Porterfield, A. Wei, and M.S. Sepulveda Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging Nanomedicine 6 2011 879 898